HYALURONIC ACID INJECTIONS

Orthovisc

HYALURONIC ACID INJECTIONS

Orthovisc

Orthovisc® is an ultra-pure, high molecular weight injectable hyaluronic acid (HA) viscosupplement used to treat joint pain caused by osteoarthritis.

ORTHOVISC® is a multi-injection indicated for the treatment of joint pain caused by osteoarthritis, thereby improving functionality.

FDA-Approved, Non-Avian multi-dose viscosupplement with the highest HA concentration and up to 6 months of efficacy.

ORTHOVISC® restores the molecular weight, elasticity and viscosity of the osteoarthritic knee to more closely resemble the synovial fluid of a healthy knee. ORTHOVISC® contains one of the highest concentration of hyaluronan per injection than all other viscosupplements. Patients with known avian allergies may be prescribed ORTHOVISC®. It is injected into the joint in a series of three injections per therapy course, spaced one week apart.

Orthovisc: A High Molecular Weight Hyaluronic Acid Injection

Orthovisc® is an ultra-pure, high molecular weight injectable hyaluronic acid (HA) viscosupplement used to treat joint pain caused by osteoarthritis. It is comprised of highly purified sodium hyaluronate (NaHA) in physiologic saline, making it both biocompatible and resorbable. Orthovisc provides up to 6 months of efficacy with only 3 to 4 injections.1,2 This is partially based on the product’s delivery of one of the highest concentrations of HA (15 mg/mL) currently available in a multi-injection treatment.3

Key Features & Benefits

Reduction in joint pain and improvement in functionality1,2
Long-lasting results through 26 weeks1
No confirmed pseudoseptic reactions reported3
Natural, non-animal sourced HA

References

  • Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intra-articular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res 2001; (385):130 – 43.
  • Neustadt D, Caldwell J, Bell M, Wade J, and Gimbel J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (ORTHOVISC) in osteoarthritis of the knee: A randomized, controlled, multicenter trial. J. Rheumatology 2005; (32): 1928-36.
  • Anika data on file.

Related Brands